Target intelligence / Profile preview

Akirin-2 (AKIRIN2)

Target
AKIRIN2
Molecular classification
Other (nuclear regulatory protein, molecular adapter), Chromatin regulation factor (functions in chromatin remodeling and gene regulation), Nuclear import adapter for proteasomes
01

Overview

Akirin-2 (AKIRIN2) is a small nuclear regulatory protein that acts as a molecular adapter, bridging multi-protein complexes and playing key roles in embryonic development, innate and adaptive immune responses, myogenesis, and brain development. It is essential for the nuclear import of 20S proteasomes in vertebrates by binding both proteasomes and nuclear import receptors, enabling nuclear protein quality control and degradation. AKIRIN2 regulates chromatin remodeling and transcription, particularly at immune gene promoters like IL-6, by interacting with chromatin remodeling complexes (e.g., BAF/SWI-SNF) and adaptor proteins (e.g., IκB-ζ). Loss or knockdown of Akirin-2 impairs the expression of inflammatory cytokines, cell cycle regulators, and muscle differentiation genes, and is associated with defective proliferation, survival, and tissue-specific developmental processes. Although not a direct therapeutic target, its pivotal role in gene regulation and protein homeostasis links it to various disease processes, particularly inflammation, immunity, and cancer.

Other names
Akirin 2Akirin-2C6orf166FLJ10342dJ486L4.2FBI1fourteen-three-three beta interactant 1AKIR2
02

Mechanism of action

Not applicable, as there are no direct drugs/compounds with validated mechanisms targeting AKIRIN2.

03

Biological functions

Embryonic developmentRegulation of innate and adaptive immunity (NF-κB and TLR signaling, cytokine induction like IL-6)Chromatin remodeling and transcription regulation (especially of immune response genes)Nuclear protein quality control (proteasome import and nuclear protein degradation)Myogenesis and skeletal muscle differentiationBrain development (proliferation and survival of neural progenitor cells)Cell cycle regulation, cell proliferation, and cell survival
04

Disease associations

Cancer (regulation of cell cycle and immune response, as well as chromatin state, are implicated in oncogenesis)Inflammatory diseases (regulation of cytokines such as IL-6)Developmental disordersPotential indirect associations with neurodevelopmental disorders (based on brain development role)Infection (immunity regulation)
05

Safety considerations

Essential for cell viability and protein quality control in the nucleus, suggesting on-target toxicities (such as impaired nuclear protein degradation and cell cycle defects) if modulatedLoss of AKIRIN2 causes defects in immune signaling, chromatin regulation, and developmental lethality in some model systems
06

Interacting drugs

None currently known as direct modulators/inhibitors/activators of AKIRIN2; no drugs specifically target Akirin-2.
07

Biomarkers

AKIRIN2 itself can be monitored as a marker of cell differentiation or inflammatory states in experimental or exploratory contexts, but is not currently an established clinical biomarkerDownstream molecules (such as IL-6) may be indirectly influenced by AKIRIN2 activity in immunological studies

Beyond the preview

Go deeper on Akirin-2 (AKIRIN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akirin-2 (AKIRIN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call